1. Micheliolide Protects Against Doxorubicin-Induced Cardiotoxicity in Mice by Regulating PI3K/Akt/NF-kB Signaling Pathway
   Ashkan Kalantary-Charvadeh et al, 2019, Cardiovascular Toxicology CrossRef
2. Inhibition of the leptin-induced activation of the p38 MAPK pathway contributes to the protective effects of naringin against high glucose-induced injury in H9c2 cardiac cells
   JINGFU CHEN et al, 2014, International Journal of Molecular Medicine CrossRef
3. Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity
   Jie-Ning Zhu et al, 2017, Scientific Reports CrossRef
4. Transcriptional Suppression of the NLRP3 Inflammasome and Cytokine Release in Primary Macrophages by Low-Dose Anthracyclines
   Nilay Köse-Vogel et al, 2019, Cells CrossRef
5. Molecular mechanisms and cardiovascular implications of cancer therapy-induced senescence
   Ibrahim Y. Abdelgawad et al, 2021, Pharmacology & Therapeutics CrossRef
6. Adriamycin-induced cardiomyopathy can serve as a model for diabetic cardiomyopathy – a hypothesis
   Kaviyarasi Renu et al, 2017, Asian Pacific Journal of Tropical Biomedicine CrossRef
7. Fisetin, a plant flavonoid ameliorates doxorubicin-induced cardiotoxicity in experimental rats: the decisive role of caspase-3, COX-II, cTn-I, iNOs and TNF-α
   Tao Ma et al, 2019, Molecular Biology Reports CrossRef
8. Exogenous H2S protects H9c2 cardiac cells against high glucose-induced injury and inflammation by inhibiting the activation of the NF-κB and IL-1β pathways
   WENMING XU et al, 2015, International Journal of Molecular Medicine CrossRef
9. Strategies to increase cardioprotection through cardioprotective chemokines in chemotherapy-induced cardiotoxicity
   Habib Haybar et al, 2018, International Journal of Cardiology CrossRef
10. Phenyl-2-aminoethyl selenide ameliorates hippocampal long-term potentiation and cognitive deficits following doxorubicin treatment
    Ahmad H. Alhowail et al, 2023, PLOS ONE CrossRef
11. Human adipose-derived stem cells preconditioned with a novel herbal formulation Jing Shi attenuate doxorubicin-induced cardiac damage
    Dennis Jine-Yuan Hsieh et al, 2023, Aging CrossRef
12. Predicting Risk of Emerging Cardiotoxicity
    Megan Goins et al, 2023, Novel Pathogenesis and Treatments for Cardiovascular Disease CrossRef
13. Heterotrimeric complex of p38 MAPK, PKCδ, and TIRAP is required for AP1 mediated inflammatory response
    Mirza S. Baig et al, 2017, International Immunopharmacology CrossRef
14. Long non-coding RNA (lncRNA) nuclear enriched abundant transcript 1 (NEAT1) promotes the inflammation and apoptosis of otitis media with effusion through targeting microRNA (miR)-495 and activation of p38 MAPK signaling pathway
    Yajuan Hu et al, 2021, Bioengineered CrossRef
15. Anti-inflammatory effects of shikonin in human periodontal ligament cells
    Chen Fan et al, 2018, Pharmaceutical Biology CrossRef
16. Protective effects of the exopolysaccharide Lasiodiplodan against DNA damage and inflammation induced by doxorubicin in rats: Cytogenetic and gene expression assays
    M.B. Mello et al, 2017, Toxicology CrossRef
17. Berberine suppresses bone loss and inflammation in ligature-induced periodontitis through promotion of the G protein-coupled estrogen receptor-mediated inactivation of the p38MAPK/NF-κB pathway
    Liping Gu et al, 2021, Archives of Oral Biology CrossRef
18. Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
    Fernando Ezquer et al, 2015, Stem Cell Research & Therapy CrossRef
19. Mechanical stretch regulates microRNA expression profile via NF-κB activation in C2C12 myoblasts
    Wenxi Hua et al, 2016, Molecular Medicine Reports CrossRef
20. Angiotensin-(1-7) reduces doxorubicin-induced aortic arch dysfunction in male and female juvenile Sprague Dawley rats through pleiotropic mechanisms
    Omeed Rahimi et al, 2022, Peptides CrossRef
21. Naringin inhibits growth and induces apoptosis by a mechanism dependent on reduced activation of NF-κB/COX-2-caspase-1 pathway in HeLa cervical cancer cells
    LAN ZENG et al, 2014, International Journal of Oncology CrossRef
22. Oxidative Stress-Driven Cardiotoicity of Cancer Drugs
    Thalita Basso Scandolara et al, 2019, Oxidative Stress in Heart Diseases CrossRef
23. In-vitro and in-vivo studies of two-drug cocktail therapy targeting chemobrain via the Nrf2/NF-κB signaling pathway
    Arti Singh et al, 2024, Journal of Molecular Histology CrossRef
24. Mechanisms of Cardiovascular Toxicities Induced by Cancer Therapies and Promising Biomarkers for Their Prediction: A Scoping Review
    Tingting Yan et al, 2024, Heart, Lung and Circulation CrossRef
25. MicroRNA-135a is up-regulated and aggravates myocardial depression in sepsis via regulating p38 MAPK/NF-κB pathway
    Ge Zheng et al, 2017, International Immunopharmacology CrossRef
26. RETRACTED: Silencing circANKRD36 protects H9c2 cells against lipopolysaccharide-induced injury via up-regulating miR-138
    Shengwei Shi et al, 2019, Experimental and Molecular Pathology CrossRef
27. Unraveling the biomechanistic role of Rac1/TWEAK/Fn14/NF‐κB intricate network in experimentally doxorubicin‐induced cardiotoxicity in rats: The role of curcumin
    Nema A. Soliman et al, 2021, Journal of Biochemical and Molecular Toxicology CrossRef
28. Novel components in the nuclear factor-kappa B (NF-κB) signaling pathways of endothelial cells under hyperglycemic-ischemic conditions
    Madhu V. Singh et al, 2024, Frontiers in Cardiovascular Medicine CrossRef
29. Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators
    Sheng Zhang et al, 2019, BMC Complementary and Alternative Medicine CrossRef
30. Exogenous hydrogen sulfide exerts proliferation/anti-apoptosis/angiogenesis/migration effects via amplifying the activation of NF-κB pathway in PLC/PRF/5 hepatoma cells
    YULAN ZHEN et al, 2015, International Journal of Oncology CrossRef
31. Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia/reperfusion injury following acute myocardial infarction
    Xin Li et al, 2017, Biochemical and Biophysical Research Communications CrossRef
32. The Role of Nrf2 and Inflammation on the Dissimilar Cardiotoxicity of Doxorubicin in Two-Time Points: a Cardio-Oncology In Vivo Study Through Time
    Ana Reis-Mendes et al, 2024, Inflammation CrossRef
33. Seaweed Sargassum aquifolium extract ameliorates cardiotoxicity induced by doxorubicin in rats
    Rania Samir et al, 2023, Environmental Science and Pollution Research CrossRef
34. Ginger Extract Loaded into Chitosan Nanoparticles Enhances Cytotoxicity and Reduces Cardiotoxicity of Doxorubicin in Hepatocellular Carcinoma in Mice
    Hend E. Abo Mansour et al, 2021, Nutrition and Cancer CrossRef
35. Effect of alteration of caveolin‐1 expression on doxorubicin‐induced apoptosis in H9c2 cardiac cells
    Akira Takaguri et al, 2015, Cell Biology International CrossRef
36. Anti-Inflammatory Therapeutic Mechanisms of Natural Products: Insight from Rosemary Diterpenes, Carnosic Acid and Carnosol
    Solomon Habtemariam, 2023, Biomedicines CrossRef
37. Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies
    Andrijana Lazic et al, 2022, International Journal of Molecular Sciences CrossRef
38. Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: Old drug with a new vision
    Ashif Iqubal et al, 2019, Life Sciences CrossRef
39. Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity
    Shuxu Du et al, 2018, Frontiers in Pharmacology CrossRef
40. Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy
    Kendall B. Wallace et al, 2020, Circulation Research CrossRef
41. Isoliquiritigenin prevents Doxorubicin-induced hepatic damage in rats by upregulating and activating SIRT1
    Wahidah H. Al-Qahtani et al, 2022, Biomedicine & Pharmacotherapy CrossRef
42. Role of TLR‑4 in anti‑β2‑glycoprotein I‑induced activation of peritoneal macrophages and vascular endothelial cells in mice
    Meiyun Wang et al, 2019, Molecular Medicine Reports CrossRef
43. NH4Cl treatment prevents doxorubicin-induced myocardial dysfunction in vivo
    Xin Huang et al, 2019, Life Sciences CrossRef
44. Sitagliptin Potentiates the Anti-Neoplastic Activity of Doxorubicin in Experimentally-Induced Mammary Adenocarcinoma in Mice: Implication of Oxidative Stress, Inflammation, Angiogenesis, and Apoptosis
    Mohamed M. Salama et al, 2022, Scientia Pharmaceutica CrossRef
45. Tyrosine phosphatase STEP is a key regulator of glutamate-induced prostaglandin E2 release from neurons
    Sathyanarayanan Rajagopal et al, 2021, Journal of Biological Chemistry CrossRef
46. Impact of peroxisome proliferator activated receptor agonist drugs in a model of nephrotoxicity in rats
    Azza A. Ali et al, 2023, Journal of Biochemical and Molecular Toxicology CrossRef
47. Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity, apoptosis, and lipid peroxidation
    Ahmad H. Alhowail et al, 2019, Toxicology Mechanisms and Methods CrossRef
48. Ethanol extracts of Rhaponticum uniflorum (L.) DC flowers attenuate doxorubicin-induced cardiotoxicity via alleviating apoptosis and regulating mitochondrial dynamics in H9c2 cells
    Boqin Hu et al, 2022, Journal of Ethnopharmacology CrossRef
49. The Grape Fruit Bioflavonoid Naringin Protects Against the Doxorubicin-Induced Micronuclei Formation in Mouse Bone Marrow
    Ganesh Chandra Jagetia, 2016, International Journal of Molecular Biology CrossRef
50. Renoprotective effects of umbelliferone on methotrexate-induced renal injury through regulation of Nrf-2/Keap-1, P38MAPK/NF-κB, and apoptosis signaling pathways
    Emad H.M. Hassanein et al, 2018, Food and Chemical Toxicology CrossRef
51. Effect of co-treatment with doxorubicin and verapamil loaded into chitosan nanoparticles on diethylnitrosamine-induced hepatocellular carcinoma in mice
    HE Abo Mansour et al, 2020, Human & Experimental Toxicology CrossRef
52. Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2
    Kristin Franke et al, 2021, International Journal of Molecular Sciences CrossRef
53. IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
    Nicholas R. Hum et al, 2022, Frontiers in Oncology CrossRef
54. Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in mice
    Jin Sin Koh et al, 2015, Free Radical Biology and Medicine CrossRef
55. Docosahexaenoic Acid Attenuates Doxorubicin-induced Cytotoxicity and Inflammation by Suppressing NF-κB/iNOS/NO Signaling Pathway Activation in H9C2 Cardiac Cells
    Zhi-Quan Wang et al, 2016, Journal of Cardiovascular Pharmacology CrossRef
56. Diet Quality, Inflammation, and Quality of Life in Breast Cancer Survivors: A Cross-Sectional Analysis of Pilot Study Data
    Tonya S. Orchard et al, 2018, Journal of the Academy of Nutrition and Dietetics CrossRef
57. Cardioprotective effects of alpha‐mangostin on doxorubicin‐induced cardiotoxicity in rats
    Farhad Eisvand et al, 2022, Phytotherapy Research CrossRef
58. Ophiopogonin D Attenuates Doxorubicin-Induced Autophagic Cell Death by Relieving Mitochondrial Damage In Vitro and In Vivo
    Ying-Yu Zhang et al, 2015, Journal of Pharmacology and Experimental Therapeutics CrossRef
59. Protective effects of curcumin on chemical and drug-induced cardiotoxicity: a review
    Fatemeh Yarmohammadi et al, 2021, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
60. The Role of the NLRP3 Inflammasome in the Molecular and Biochemical Mechanisms of Cervical Ripening: A Comprehensive Review
    Wojciech Flis et al, 2024, Cells CrossRef
61. Doxorubicin‐induces NFAT/Fas/FasL cardiac apoptosis in rats through activation of calcineurin and P38 MAPK and inhibition of mTOR signalling pathways
    Ali A. Shati, 2020, Clinical and Experimental Pharmacology and Physiology CrossRef
62. Loss of endogenous estrogen increases cardiac toxicity by doxorubicin
    Young Ho Lee et al, 2017, Journal of Biomedical Translational Research CrossRef
63. Blockade of L-type Ca2+ channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway
    Soichiro Ikeda et al, 2019, Scientific Reports CrossRef
64. Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice
    Bidya Dhar Sahu et al, 2016, Life Sciences CrossRef
65. Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction
    Carmine Rocca et al, 2021, International Immunopharmacology CrossRef
66. Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation
    Pei-Ling Hsieh et al, 2022, International Journal of Molecular Sciences CrossRef
67. EXercise to prevent AnthrCycline-based Cardio-Toxicity (EXACT) in individuals with breast or hematological cancers: a feasibility study protocol
    Melanie R. Keats et al, 2016, Pilot and Feasibility Studies CrossRef
68. Sulforaphane protection against the development of doxorubicin‐induced chronic heart failure is associated with Nrf2 Upregulation
    Yang Bai et al, 2017, Cardiovascular Therapeutics CrossRef
69. Exercise to Prevent Anthracycline-Based Cardiotoxicity (EXACT): A Feasibility Study
    Stefan D. Heinze-Milne et al, 2021, Translational Journal of the American College of Sports Medicine CrossRef
70. Molecular mechanisms in H 2 O 2 -induced increase in AT1 receptor gene expression in cardiac fibroblasts: A role for endogenously generated Angiotensin II
    V. Anupama et al, 2016, Journal of Molecular and Cellular Cardiology CrossRef
71. Role of GluN2A NMDA receptor in homocysteine‐induced prostaglandin E2 release from neurons
    Sathyanarayanan Rajagopal et al, 2019, Journal of Neurochemistry CrossRef
72. IFN-γ-STAT1-ERK Pathway Mediates Protective Effects of Invariant Natural Killer T Cells Against Doxorubicin-Induced Cardiomyocyte Death
    Masashi Sada et al, 2023, JACC: Basic to Translational Science CrossRef
73. The role of senescence in cancer therapy-associated cardiovascular toxicity
    Yasmin K. Alshoubaki et al, 2024, The Journal of Cardiovascular Aging CrossRef
74. Apoptotic and Anti-Inflammatory Effects of Eupatorium japonicum Thunb. in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
    Jong-Il Shin et al, 2018, BioMed Research International CrossRef
75. Cardioprotective effects of corilagin on doxorubicin induced cardiotoxicity via P13K/Akt and NF-κB signaling pathways in a rat model
    Jing Huang et al, 2022, Toxicology Mechanisms and Methods CrossRef
76. Nrf2: a dark horse in doxorubicin-induced cardiotoxicity
    Xiaopeng Zhao et al, 2023, Cell Death Discovery CrossRef
77. The role of inflammation and antioxidant defenses in the cardiotoxicity of doxorubicin in elderly CD-1 male mice
    Ana Reis-Mendes et al, 2023, Archives of Toxicology CrossRef
78. 8-Formylophiopogonanone B antagonizes doxorubicin-induced cardiotoxicity by suppressing heme oxygenase-1-dependent myocardial inflammation and fibrosis
    Dan Qin et al, 2021, Biomedicine & Pharmacotherapy CrossRef
79. Postnatal growth retardation is associated with deteriorated intestinal mucosal barrier function using a porcine model
    Ming Qi et al, 2021, Journal of Cellular Physiology CrossRef
80. Effects of High-Linear-Energy-Transfer Heavy Ion Radiation on Intestinal Stem Cells: Implications for Gut Health and Tumorigenesis
    Santosh Kumar et al, 2024, Cancers CrossRef
81. Early Moderate Intensity Aerobic Exercise Intervention Prevents Doxorubicin-caused Cardiac Dysfunction through Inhibition of Cardiac Fibrosis and Inflammation
    Hsin-Lun Yang et al, 2020, Cancers CrossRef
82. Early myocardial changes induced by doxorubicin in the nonfailing dilated ventricle
    Patricia G. Rodrigues et al, 2019, American Journal of Physiology-Heart and Circulatory Physiology CrossRef
83. Role of Inflammation and Redox Status on Doxorubicin-Induced Cardiotoxicity in Infant and Adult CD-1 Male Mice
    Ana Reis-Mendes et al, 2021, Biomolecules CrossRef
84. Cardioprotective Effects of Latifolin Against Doxorubicin-Induced Cardiotoxicity by Macrophage Polarization in Mice
    Ni Zhang et al, 2020, Journal of Cardiovascular Pharmacology CrossRef
85. Natural compounds against cytotoxic drug‐induced cardiotoxicity: A review on the involvement of PI3K/Akt signaling pathway
    Fatemeh Yarmohammadi et al, 2021, Journal of Biochemical and Molecular Toxicology CrossRef
86. Fibroblast Growth Factor Type 1 Ameliorates High-Glucose-Induced Oxidative Stress and Neuroinflammation in Retinal Pigment Epithelial Cells and a Streptozotocin-Induced Diabetic Rat Model
    Hsin-Wei Huang et al, 2021, International Journal of Molecular Sciences CrossRef
87. Recombinant immunotoxin induces tumor intrinsic STING signaling against head and neck squamous cell carcinoma
    Guiqin Xie et al, 2023, Scientific Reports CrossRef
88. Stress Kinase Signaling in Cardiac Myocytes
    Xun Ai et al, 2022, Cardiovascular Signaling in Health and Disease CrossRef
89. Losmapimod ameliorates doxorubicin-induced cardiotoxicity through attenuating senescence and inflammatory pathways
    Mohamed S. Dabour et al, 2024, Biomedicine & Pharmacotherapy CrossRef
90. Mitogen-Activated Protein Kinases Pathways Mediate the Sunitinib-Induced Hypertrophy in Rat Cardiomyocyte H9c2 Cells
    Hesham Mohamed Korashy et al, 2015, Cardiovascular Toxicology CrossRef
91. Role of Reactive Oxygen Species in Cancer Progression
    Dharambir Kashyap et al, 2019, Current Pharmacology Reports CrossRef
92. Fasudil Protects Against Adriamycin-induced Acute Heart Injury by Inhibiting Oxidative Stress, Apoptosis, and Cellular Senescence
    Yi Yan et al, 2022, Current Pharmaceutical Design CrossRef
93. Updates in Anthracycline-Mediated Cardiotoxicity
    Canan G. Nebigil et al, 2018, Frontiers in Pharmacology CrossRef
94. Quercetin and its potential therapeutic effects on aluminum phosphide-induced cardiotoxicity in rats: Role of NOX4, FOXO1, ERK1/2, and NF-κB
    Enas M.A. Mostafa et al, 2024, Tissue and Cell CrossRef
95. Angiotensin-(1–9) attenuates adriamycin-induced cardiomyopathy in rats via the angiotensin type 2 receptor
    Hui Ma et al, 2024, Molecular and Cellular Biochemistry CrossRef
96. Research progress on the role and mechanism of Sirtuin family in doxorubicin cardiotoxicity
    Xuan Zhang et al, 2024, Phytomedicine CrossRef
97. Betaine ameliorates doxorubicin‐induced cardiomyopathy by inhibiting oxidative stress, inflammation, and fibrosis through the modulation of AMPK/Nrf2/TGF‐β expression
    Sumeet Kumar Singh et al, 2024, Environmental Toxicology CrossRef
98. Decreasing doxorubicin-induced cardiotoxicity with Nigella sativa seed extract: Traditional medicine targeting a severe clinical problem
    Paulo J. Oliveira, 2022, Revista Portuguesa de Cardiologia CrossRef
99. Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis
    Reem Ali Shaker et al, 2018, BMC Pharmacology and Toxicology CrossRef
100. Naringin protects myocardial cells from doxorubicin-induced apoptosis partially by inhibiting the p38MAPK pathway
     Chun-Yan Jian et al, 2017, Molecular Medicine Reports CrossRef
101. Cardamonin protects against doxorubicin-induced cardiotoxicity in mice by restraining oxidative stress and inflammation associated with Nrf2 signaling
     Wang Qi et al, 2020, Biomedicine & Pharmacotherapy CrossRef
102. Inflammatory mediators in a short-time mouse model of doxorubicin-induced cardiotoxicity
     Michela Pecoraro et al, 2016, Toxicology and Applied Pharmacology CrossRef
103. Overfeeding during Lactation in Rats is Associated with Cardiovascular Insulin Resistance in the Short-Term
     Daniel González-Hedström et al, 2020, Nutrients CrossRef